Earnings results expected in 80 days
Summary
547A trading today lower at €13.39, a decrease of 0.45% from yesterday's close, completing a monthly decrease of -13.89% or €2.16. Over the past 12 months, 547A stock lost -4.43%.
547A is not paying dividends to its shareholders.
The last earnings report, released on May 07, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 22, 2025.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
Want to track 547A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
547A Chart
Loading, please wait...
Ambu A/S Dividends
 547A 5 months ago | Other | €0.05 Per Share |
| 547A 15 Dec 2021 | Other | €0.04 Per Share |
| 547A 10 Dec 2020 | Other | €0.04 Per Share |
| 547A 18 Dec 2019 | Other | €0.05 Per Share |
| 547A 13 Dec 2018 | Other | €0.05 Per Share |
Ambu A/S Earnings
| 22 Aug 2025 (80 Days) Date | | - Cons. EPS | - EPS |
| 7 May 2025 Date | | - Cons. EPS | - EPS |
| 30 Jan 2025 Date | | - Cons. EPS | - EPS |
| 5 Nov 2024 Date | | - Cons. EPS | - EPS |
| 30 Aug 2024 Date | | - Cons. EPS | - EPS |
| 547A 5 months ago | Other | €0.05 Per Share |
| 547A 15 Dec 2021 | Other | €0.04 Per Share |
| 547A 10 Dec 2020 | Other | €0.04 Per Share |
| 547A 18 Dec 2019 | Other | €0.05 Per Share |
| 547A 13 Dec 2018 | Other | €0.05 Per Share |
| 22 Aug 2025 (80 Days) Date | | - Cons. EPS | - EPS |
| 7 May 2025 Date | | - Cons. EPS | - EPS |
| 30 Jan 2025 Date | | - Cons. EPS | - EPS |
| 5 Nov 2024 Date | | - Cons. EPS | - EPS |
| 30 Aug 2024 Date | | - Cons. EPS | - EPS |
Ambu A/S (547A) FAQ
What is the stock price today?
The current price is €13.39.
On which exchange is it traded?
Ambu A/S is listed on XFRA.
What is its stock symbol?
The ticker symbol is 547A.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 29.62B.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Aug 22, 2025.
Has Ambu A/S ever had a stock split?
No, there has never been a stock split.
Ambu A/S Profile
| Medical - Devices Industry | Healthcare Sector | Ms. Britt Meelby Jensen CEO | XBER Exchange | DK0060946788 ISIN |
| DK Country | 5,000 Employees | 5 Dec 2024 Last Dividend | - Last Split | 18 Aug 1998 IPO Date |
Overview
Ambu A/S is a leading medical device manufacturer with a global reach, serving hospitals, clinics, and rescue services around the world. Since its establishment in 1937, the company has been dedicated to developing, producing, and marketing a wide range of medical devices. Headquartered in Ballerup, Denmark, Ambu A/S focuses on providing innovative solutions in anaesthesia, patient monitoring, diagnostics, endoscopy, neurology, and cardiology. Their commitment to healthcare and emergency services has made them a key player in the medical devices industry.
Products and Services
- Anaesthesia and Airway Management: The company offers a comprehensive range of products used in administering anaesthesia and managing patient airways. This includes bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. Each product is designed with patient safety and comfort in mind, facilitating effective airway management during medical procedures.
- Endoscopy Products: Ambu A/S provides medical devices for endoscopic procedures, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units. These products are engineered for diagnostics and surgeries requiring minimal invasion, allowing for more precise treatment and faster patient recovery times.
- Neurology Products: The range includes EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. These are critical in diagnosing and monitoring neurological disorders, aiding in precise and effective treatments.
- Cardiology Products: The company's cardiology portfolio covers essential tools for airway management and anaesthesia that are also applicable in cardiology, alongside specialized items like diagnostic and therapeutic devices. The emphasis is on improving cardiovascular diagnostics and patient care during procedures.
- Emergency and Training Products: To support rescue services, Ambu A/S offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. These products are designed both for field use in emergencies and for training purposes, ensuring that first responders are well-equipped and prepared.
Contact Information
Address: Baltorpbakken 13
Phone: 45 72 25 20 00
Website: https://www.ambu.com
2025 © Marketlog. All Rights Reserved.
